PharVision Advisers’s TPG TPG Stock Holding History

PharVision Advisers’s Portfolio TPG Stock Details TPG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,081	Closed	-$292K	–	1002
2025 Q3	$292K	Buy	+5,081	New	+$300K	0.16%	239

Other funds holding TPG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Darlington Partners Capital Management Greenbrae, California $2.27B AUM 18.22% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PharVision Advisers's TPG Position: Q4 2025 in Review

PharVision Advisers sold out of TPG (TPG) in Q4 2025, closing a stake of 5,081 shares — an estimated $292K sold.

PharVision Advisers first reported a position in TPG in Q3 2025 and held it in 1 quarter. The position peaked at $292K in Q3 2025. 342 funds tracked by Wall St. Rank hold TPG as of Q4 2025.

PharVision Advisers reported no remaining TPG position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 5,081 TPG shares in Q4 2025, an estimated $292K.
PharVision Advisers first reported a position in TPG in Q3 2025 and held it in 1 quarter.
PharVision Advisers's TPG position peaked at $292K in Q3 2025.
342 funds tracked by Wall St. Rank held TPG as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.